Table 5 Correlation analysis of each index and grouping in patients with stage I lung cancer
| Â | Growth group (n) | Stable group (n) | P |
|---|---|---|---|
COX-2 | |||
 −  | 3 | 0 | 0.198 |
 +  | 3 | 6 | |
 ++ | 7 | 3 | |
 +++  | 7 | 7 | |
Ki-67 | |||
 −  | 4 | 1 | 0.384 |
 +  | 10 | 9 | |
 ++  | 2 | 0 | |
 +++  | 4 | 0 | |
VEGF | |||
 −  | 9 | 7 | 0.264 |
 +  | 5 | 1 | |
 ++  | 6 | 2 | |
CD44V6 | |||
 −  | 5 | 0 | 0.397 |
 +  | 2 | 7 | |
 ++  | 8 | 2 | |
 +++  | 5 | 1 | |
EGFR | |||
 −  | 3 | 0 | 0.575 |
 +  | 4 | 1 | |
 ++  | 4 | 5 | |
 +++  | 9 | 4 | |
MDM-2 | |||
 −  | 9 | 4 | 0.795 |
 +  | 6 | 5 | |
 ++  | 3 | 1 | |
 +++  | 2 | 0 | |
TGF-β1 | |||
 −  | 3 | 0 | 0.889 |
 +  | 5 | 3 | |
 ++  | 7 | 6 | |
 +++  | 5 | 1 | |